10:02 AM EDT, 07/17/2025 (MT Newswires) -- 10x Genomics ( TXG ) said Thursday it plans a collaborative study with A*STAR Genome Institute of Singapore to use spatial biology and artificial intelligence to advance drug target discovery.

The collaboration will leverage 10x Genomics' ( TXG ) Xenium platform along with AI to analyze tissue samples to further drug target discovery for cancer and inflammatory diseases, the company said.

Price: 12.54, Change: +0.17, Percent Change: +1.37